机构:[1]Affiliated Hosp Hebei Univ,Dept Med Oncol,Baoding,Peoples R China医疗肿瘤内科河北大学附属医院重点学科肿瘤内科[2]Tianjin Med Univ, Canc Inst & Hosp, Dept Hematol, Tianjin, Peoples R China[3]Natl Clin Res Ctr Canc, Tianjin, Peoples R China[4]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China[5]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
Objective: The incidence of MM in most registries remains stable or showing only a slightly increase. However, prevalence of MM is increasing due to the increase in overall survival in the last two decades. The aim of this study was to observe changes in biochemical parameters during the diagnosis and treatment of MM. Methods: A retrospective analysis was made of the biochemical indicators, survival time, and related adverse events of 196 patients with MM. Results: Of the 196 patients with MM, 26 were diagnosed with DM (DM-MM group) at the first diagnosis, 31 with steroid-induced diabetes mellitus (SID-MM group) during treatment, and 139 without DM (MM group). There was no significant difference between the three groups in the mean age of onset, sex ratio, incidence of hypercalcemia, renal dysfunction, anemia, abnormal lactate dehydrogenase, and median value of D-dimer and fibrinogen during diagnosis and treatment. There was no significant difference in survival time between the SID-MM and MM groups, but there was a significant difference between the DM-MM and MM groups. Conclusion: There was no significant difference between the three groups in the incidence of hypercalcemia, anemia, and renal function impairment. The survival time of patients with DM was shorter than that of patients without DM.
第一作者机构:[1]Affiliated Hosp Hebei Univ,Dept Med Oncol,Baoding,Peoples R China
通讯作者:
通讯机构:[2]Tianjin Med Univ, Canc Inst & Hosp, Dept Hematol, Tianjin, Peoples R China[3]Natl Clin Res Ctr Canc, Tianjin, Peoples R China[4]Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China[5]Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
推荐引用方式(GB/T 7714):
Dou Zheng-Yue,Xia Bing,Wang Chao-Yu,et al.Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma[J].HEMATOLOGY.2023,28(1):doi:10.1080/16078454.2023.2179218.
APA:
Dou, Zheng-Yue,Xia, Bing,Wang, Chao-Yu,Xu, Yan-Jie&Zhang, Yi-Zhuo.(2023).Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma.HEMATOLOGY,28,(1)
MLA:
Dou, Zheng-Yue,et al."Influence of diabetes mellitus on the biochemical parameters and outcomes of multiple myeloma".HEMATOLOGY 28..1(2023)